Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — Everything You Ought to Know About the Marijuana Entourage Effect

Cannabis has become extremely popular over the past decade thanks to chemical compounds called cannabinoids. Produced by plants in the hemp family, these compounds interact with the body in unique ways and give rise to a variety of effects. THC is the main psychoactive compound responsible for marijuana’s intoxicating effects while cannabidiol (“CBD”) is medicinal and is claimed to be effective against a wide variety of symptoms.

Cannabis actually produces more than 100 cannabinoids as well as terpenes and flavonoids, but because of its federal status as a Schedule I controlled substance, little research has been conducted into these lesser-known compounds.

In the past few years, scientists have been able to study cannabis more closely, and one theory has become prevalent. Individually, THC and CBD could have their therapeutic benefits, but together, they somehow enhance each other’s beneficial effects while tamping down on the less desirable ones. Terpenes, which are produced by other plants and are responsible for marijuana’s strong aroma, also work together with the cannabinoids to make them more impactful. This synergy is called the entourage effect, and researchers believe understanding it is key to unlocking cannabis’ true potential.

Like cannabinoids, terpenes also have therapeutic effects, and this applies to those that are present in other plants as well. For instance, pine trees produce pinene terpenes, which have anti-inflammatory properties while lavender produces linalool terpenes, which have anti-anxiety effects.

In cannabis, a terpene called myrcene seems to have strong anti-inflammatory, analgesic, antibiotic and sedative effects and can have an entourage effect when taken with THC, says Dr. Ethan Russo. He recently authored a seminal research paper titled “Taming THC: Potential Cannabis Synergy and Phytocannabinoid-Terpene Entourage Effects.”

Since cannabis has numerous cannabinoids and terpenes, the theory is that different terpene-cannabinoid and cannabinoid-cannabinoid combinations may have different effects. One study found that although THC can be quite effective at reducing cancer-related pain, it was even more effective when taken with CBD. Additionally, the study found that cannabidiol boosted THC’s analgesic effects while reducing its psychoactive effects, which can be quite helpful for those who are interested in THC’s pain-relieving abilities but don’t want to get high.

Cannabinoids such as THC interact with the endocannabinoid system (“ECS”), which is in charge of regulating functions such as pain, sleep and appetite. These are all functions that contribute to the body’s internal balance or homeostasis. CBD, on the other hand, doesn’t interact with the ECS, but it affects how THC binds with endocannabinoid receptors. Scientists don’t know exactly what causes this, but understanding how this system of receptors and cannabinoids and terpenes alter functionality could allow scientists to harness the entourage effect and open up cannabis to a wider variety of medical applications.

As firms such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) continue to bring innovative cannabis-based beverages to the market, consumers can expect to get a taste of the different cannabinoid, terpene and flavonoid combinations possible.

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Issues Letter to Shareholders

Golden Triangle Ventures (OTC: GTVH) (“GTV”), a multifaceted consulting company pursuing ventures across health, entertainment and technology industries, today released a mid-year letter to shareholders that provides updates on current activities and outlines its corporate strategy. “Over the past six months, our company has acquired several very exciting businesses and projects that all synergistically work together in their own way. Due to the many things that have recently transpired, we all felt that it was important to provide a formal update on all the developments that have come to fruition within Golden Triangle Ventures. One year ago, we knew exactly what we were going to build but we did not know it was going to be this amazing,” reads the letter from GTV CEO Steffan Dalsgaard. “As our company continues to disclose the many additional projects we are working to develop, and all the accomplishments that transpire within these projects, the world will understand the true vision of Golden Triangle Ventures and the synergies between our businesses. I truly believe that we are building a company that will greatly impact the industries we do business in, and I strongly think the world will understand my confidence after all our projects come to light. Every single day we see miracles that transpire within our business, and I am honored for the opportunity to put everything I can into this company for all our shareholders. We look forward to disclosing many more accomplishments with the world as they develop, and I will never stop pushing for this company’s future.”

To view the full press release, visit https://cnw.fm/lFaD9

About Golden Triangle Ventures Inc.

Golden Triangle Ventures (“GTV”) is a multifaceted consulting company pursuing ventures in the health, entertainment and technology industries, with many additional projects being developed that provide synergistic values to these divisions. The company aims to purchase, acquire and/or joint venture with established entities that management can help assist and develop into unique opportunities. Additionally, GTV provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion and commitment to these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent these three sectors in which the company aims to do business. For more information, visit the company’s website at www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://cnw.fm/GTVH

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks — Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Featured in Article Discussing Cannabis Leaders and Lessons

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, is featured in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. The article, titled “A Lesson in Cannabis: Second Mover Can Be Better Position,” looks at what companies looking to grow in the cannabis market can learn from pioneers in the space. “Even though medical marijuana had been legal in some U.S. states for more than a decade, the substance didn’t gain much recognition until Colorado set the market on its head in 2012 by making adult-use marijuana legal. Since then, other states have followed suit, while in 2018, Canada went all-in to become the first developed nation with weed legalized at the federal level,” the article states. “Not surprisingly, North American companies and investors were tripping over themselves trying to capitalize on the massive burgeoning market. In all market segments, plenty of lessons were learned as everyone from companies to investors to lawmakers worked to organize a brand-new market.”

To view the full press release, visit https://cnw.fm/xE6lm

About Red White & Bloom Brands Inc.

Red White & Bloom Brands is positioning itself to be one of the top-three, multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on major U.S. markets, including Michigan, Illinois, Massachusetts, Arizona and California, with respect to cannabis, as well as the United States and internationally for hemp-based CBD products. For more information about the company, please visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) Announces Shipment of Proprietary Dry Herb Inhalers for Use in Pilot Program

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has completed an initial shipment of its proprietary RYAH Smart Dry Herb Inhalers. The shipment was sent to Medicann in Jersey, the largest of the Channel Islands, located between England and France. A premier cannabis-specialized clinic, Medicann plans to use the inhalers for use in a pilot program designed to collect patient feedback regarding consumption of cannabis strains that are available on the island. According to the announcement, the parties will also be working on defining an exclusive, definitive supply and distribution agreement that would name Medicann as the sole supplier and distributor of the RYAH Smart Dry Herb Inhalers in the region. “We are excited to be initiating our pilot program with Medicann in Jersey, which represents a unique, ‘ring-fenced’ environment for establishing potentially numerous studies on the efficacy of treatments using plant-based therapies,” said RYAH Group CEO Gregory Wagner in the press release. “RYAH is pleased to contribute RYAH’s IoT devices and data platform and work with Medicann toward perfecting prescribing practices and dosing regimens.”

To view the full press release, visit https://nnw.fm/YIBSg

About RYAH Group Inc.

RYAH Group is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. Its robust artificial intelligence platform aggregates and correlates HIPAA-compliant patient data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is relevant for clinics, doctors, dispensaries and pharmaceutical companies and licensed processors (“LPs”) to monitor and manage formulation effects on patients and demographics. With a strong IP (“IP”) portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle. For more information about the company, please visit www.RyahGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://cnw.fm/RYAH

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Enters Exclusive Sales, Distribution Agreement for Mexico and Central America

Green Hygienics (OTCQB: GRYN) has signed an exclusive sales and distribution agreement for Mexico and Central America; the company signed the agreement with Inter Cargo and ABA Cargo, two sister companies that boast a successful 50-year sales and distribution track record in Mexico and other Latin American countries. According to the announcement, Inter Cargo and ABA Cargo will use their impressive sales, marketing, logistics and retail expertise to distribute Green Hygienics’ full line of high-quality CBD products. “We are excited to have this agreement in place for strategic, wide-scale distribution of our highly differentiated, safe and superior quality CBD hemp products,” said Green Hygienics COO Kyle MacKinnon in the press release. “Entering into an agreement with our new partners, who have more than 50 years of history in the retail business in Mexico, allows us to tap into a network of leading retailers, presenting Green Hygienics with a first-to-market opportunity to have a retail presence in the largest emerging cannabis market in the world. After proving concept with our ability to cultivate at our property, the largest single USDA Certified Organic hemp for CBD farm in North America, and through recent acquisitions, we have shifted focus to sales and distribution to create revenue for the company. This agreement represents a clear path forward to bring value to our shareholders.”

To view the full press release, visit https://cnw.fm/tNVWM

About Green Hygienics Holdings Inc.

Green Hygienics is a California-based innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with consumer packaged goods (“CPG”) and pharmaceutical companies. For more information about the company, visit www.GreenHygienics.com

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Massachusetts Regulators Extend Cannabis Telehealth, Curbside Pickup

At the onset of the coronavirus pandemic last year, the Massachusetts Cannabis Control Commission permitted medical cannabis patients to access telehealth appointments and have their prescriptions delivered for curbside pickup in an attempt to increase safety. Consumers were allowed to place their orders either online or via phone; they could then pick up those orders curbside at the stores.

Now, the agency notes, the measures will be allowed to continue for an extended period, despite the State of Emergency declared by Gov. Charlie Baker of Massachusetts coming to an end. The State of Emergency was initially declared in the state on March 10, 2020.

While issuing final administrative orders at the start of this week, the Cannabis Control Commission’s executive director, Shawn Collins, stated that virtual community outreach meetings, telehealth consults and curbside operations would be allowed to continue until Sept. 1, 2021.However, this date could change if the administrative orders are amended or the commission revokes the order.

For medical patients, clinical visits for purposed such as renewal and consultation can carry on through telehealth appointments. Additionally, individuals who have yet to register but would like to do so are encouraged to do so through telehealth up until September 1. The order notes that after the aforementioned date, clinical visits can occur either by telehealth or in person. As per medical-use regulations, however, any first-time patient will have to visit a clinic in person in order to be issued with an initial certificate of registration.

In addition to this, marijuana dispensaries can continue to carry out sales for curbside pickup by electronic means and by phone. This, the order asserts, will help keep both customers and patients safe.

The commission also stated that virtual meetings could be conducted by any individual who would like to host a community outreach meeting, as it would be safe and also allow those who couldn’t attend physical gatherings to also take part in them.

In other news, Cloud Creamery is planning on launching marijuana-infused ice cream in the state, as summer sets in. Residents in the state already have access to edible chocolate bars and gummies. Now, David Yusefzadeh of Cloud Creamery wants to heighten the edibles experience by utilizing local products, which will not only attract new consumers but also boost the industry’s growth.

At the start of the month, the state’s Cannabis Control Commission issued a notice to Cloud Creamery, giving the company the go ahead to begin manufacturing operations. The product will be available at Caroline’s Cannabis in Uxbridge, Western Front in Chelsea and Bud’s Goods and Provisions in Worcester.

Yusefzadeh also plans to bring traffic to minority and women-owned dispensaries, when the product begins to be offered at dispensaries.

The extension of telehealth services and curbside pickups is a good move as it recognizes how important medical cannabis products are to the people who need them. These benefits can further be exploited by making use of the range of products, such as the remote IoT dose-measuring device,made by RYAH Group Inc. (CSE: RYAH) to help patients take precise doses of their plant medicine.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Medical Marijuana Activists in Pennsylvania See Workers’ Comp. Decision as a Win

Thirty-six states in America have legalized cannabis for medical use, and an estimated 3.6 million individuals are registered as medical cannabis patients in the United States. However, federal law classifies cannabis as a Schedule I controlled substance with no accepted medical use; cannabis is ranked right alongside hard drugs such as cocaine and heroin. Consequently, insurance companies refuse to cover individuals who use medical cannabis to treat work-related injuries. Instead, most of these patients have to pay for their medical cannabis out of pocket.

In Pennsylvania, however, a workers’ compensation judge made a historic and possibly precedent-setting ruling after declaring that an employee who was hurt while on the job and used medical marijuana to ease her pain deserved to be compensated by her former employer’s insurance provider. According to the plaintiff’s lawyer, Dana Kaufman from Kaufman Workers’ Compensation Law, this is the first time there has been such a ruling in Pennsylvania. Kaufman, whose firm operates out of Abington Township, has been trying to help her clients recover the costs they incurred after using cannabis to treat pain caused by workplace injuries. Until now, she has been unsuccessful.

Kaufman’s client, a home health aide, suffered serious injuries in a car accident that occurred as she drove from one client’s residence to another. After a car veered into her lane and hit her head on, her car flipped, and she was trapped inside, grievously injured, for 20 minutes. She suffered a trio of broken ribs as well as fractures to her legs, toes, and foot; she also sustained injuries to her hands and wrist. She was admitted to a trauma hospital for 10 days, and although she eventually recovered, she was left with nerve pain in one ankle and a leg that caused her immense pain and often woke her up at night.

Since she didn’t want to rely on opioids and other drugs that had side effects which made her unable to work effectively, she turned to a medical cannabis oil that she put into capsules and took daily. This reduced her pain enough for her to work two jobs as a daycare attendant and a home health aide for a cumulative 32 hours a week. Judge Rochelle Quiggle at the Pottsville, Pennsylvania, field office ruled that the plaintiff’s claims were more than reasonable and ordered her former boss’ insurance provider to pay her back around $4,000 and cover her medical marijuana costs ($400 a month) moving forward.

This is Kaufman’s first such win, and she says that she has several pending appeals at the Workers’ Compensation Appeals Board and Commonwealth Court. Although it is now common knowledge that opioids have plenty of negative side effects, with even some insurance companies refusing to cover certain pharmaceutical pain relievers, those companies still won’t cover medical cannabis costs. She hopes that this ruling will change this trend and push more insurance providers to cover individuals using medical-grade cannabis to treat work-related injuries.

As more companies such as XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) take their cannabis-based formulations through the clinical trial process, a time may come when insurers will cover cannabis medicines since they will have gone through the regulatory process.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://cnw.fm/XPHYF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Golden Triangle Ventures Inc. (GTVH) to be Featured in 12-Part ‘New to the Street’ Interview Series

Golden Triangle Ventures (OTC: GTVH) (“GTV”), a multifaceted consulting company pursuing ventures across health, entertainment and technology industries, has partnered with “New to the Street,” which spotlights companies on national television. FMW Media today announced that its business TV show has begun filming on the series covering GTVH. According to the update, Jane King, the TV show’s host, interviews Steffan Dalsgaard, CEO of Golden Triangle Ventures, who discusses the company’s milestones, growth, operational fundamentals and successful divisions throughout the 12-part televised series. Starting in July 2021, New to the Street’s broadcasting of the filming of its interviews with Golden Triangle Ventures can be seen on its Sunday Newsmax TV slot, from 10-11 a.m. ET. Also, in July 2021, the interviews will be available on the Fox Business Network’s Monday broadcast, with exact dates and times to be announced.

To view the full press release, visit https://cnw.fm/AwcBq

About Golden Triangle Ventures Inc.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://cnw.fm/GTVH

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Canadian Firms Hope the US Eases Marijuana Restrictions

After decades of prohibition and intense policing, the American states are finally loosening restrictions against cannabis. So far, 36 states allow medical marijuana, 16 states have legalized recreational medical cannabis, and several more states are considering whether or not to pass cannabis legislation. The state-legal cannabis sector has been insanely profitable so far, earning billions of dollars in revenue and providing states with plenty of tax revenue, even amid the coronavirus pandemic, while other industries faltered.

Consequently, cannabis firms from the Great White North have been eyeing the U.S. market, waiting for the government to pass federal decriminalization laws before swooping in to for a piece of the cake. With President Joseph Biden in the White House and Capitol Hill currently in the Democrats’ control, there has never been a more ideal time for cannabis to come out from under the shackles of federal prohibition. However, the ongoing coronavirus pandemic has held the Biden administration’s attention for nearly one and a half years, and with the 2022 midterms approaching, there is a risk the Democrats may lose their tenuous hold on Capitol Hill.

David Culver, vice president of global government relations for Canadian cannabis firm Canopy Growth Corp., says these legislative changes will need to happen soon before Biden’s potentially narrow legislative window closes. Although Biden has said he supports medical marijuana, decriminalizing cannabis, and updating the Department of Justice’s classification of cannabis to allow cannabis research, he doesn’t support recreational cannabis. However, Senate Majority Leader Chuck Schumer supports legalizing adult-use cannabis, and he is currently working on a federal cannabis legalization bill with Senators Ron Wyden and Cory Booker.

At the moment, marijuana’s status as a Schedule I controlled substance makes it extremely difficult for even local cannabis companies to operate. But with the U.S. cannabis market projected to bring in $40 billion yearly, Canadian entities hope the United States eases restrictions, especially since the Canadian market hasn’t been as lucrative as anticipated.

In 2019, Canopy Growth had an acquisition deal with New York-based Acreage Holdings, which was amended last year and is contingent on a major “triggering event,” referring to changes to U.S. federal cannabis laws. According to Canopy Growth CEO David Klein, the U.S. is going to be a core market for the Canadian company.

Aphria Inc. acquired Atlanta-based craft beer vendor SweetWater Brewing Co. last November, and CEO Irwin Simon also believes the U.S. will be a major source of revenue for the Canadian company. But while the coronavirus pandemic rages on, Culver says the government will likely focus its efforts on the pandemic and turn its attention to cannabis in the fall.

Needless to say, other companies that already have a firm foothold in Canada, such as Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF), would relish the opportunity to enter the U.S. market and make their mark there as well.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) are available in the company’s newsroom at https://cnw.fm/PULL

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — California to Repair Drug War Ills Using Cannabis Taxes

Last week, the state of California revealed that it would be awarding roughly $29 million in grants funded by cannabis tax revenue to more than 50 not-for-profit organizations in an attempt to repair the harms of the drug war. The Governor’s Office of Business and Economic Development will be in charge of allocating the funds, which will be offered through the state’s Community Reinvestment Grants program.

The notice released by the state states that the grants to be awarded will serve communities that have been disproportionately impacted by the war on drugs. It explains that the harsh state and federal drug policies approved from the start led to the separation of families, prohibitions on public housing, loss of educational attainments because of decreased federal financial aid eligibility, diminished access to social services and the mass incarceration of individuals of color.

The grants will be given to not-for-profit organizations that fit the eligibility criteria and support programs whose objectives are to offer legal services, substance misuse treatment, mental health treatment and job placement for disproportionately affected communities.

In a press release, the director of the Governor’s Office of Business and Economic Development Dee Dee Myers, said that the state’s Community Reinvestments Grants programs was a resource aimed at helping communities conquer the barriers and systemic restrictions to equity and opportunity. She added that the grants would also help advance economic justice, wellness and health for communities and populations that were affected by the drug war.

Applications for the grants had been made available to these communities late last year in an effort to promote economic justice and public health.

In addition to California, the state of Illinois is also utilizing cannabis tax revenue to finance programs to right the wrongs of the drug war. Earlier in January, its R3 (Restore, Reinvest and Renew) program awarded more than $30 million in marijuana-backed grants.

Concurrently, marijuana tax dollars in the state of Oregon are also being used to increase access to harm reduction and substance misuse treatment programs after a broad decriminalization measure — Measure 110 — was added to the ballot and received approval from voters last year.

The Oregon Health Authority had more than $1.5 million in funds allocated to supporting the administrative costs to be incurred in the implementation of the measure. Of the other funds to be allocated, more than $8 million will be used to finance proposals that closely align with the values and priorities of the decriminalization campaign, $6.4 million is to be directed into harm reduction and addiction recovery programs while another $2.9 million will be allocated to tribal groups.

This program illustrates how establishing a legal marijuana industry that allows companies such as Sonoma Biologics Corp. to operate can be beneficial by availing taxes that can be put to use to correct the wrongs of the past.

NOTE TO INVESTORS: The latest news and updates relating to Sonoma Biologics Corp. are available in the company’s newsroom at https://cnw.fm/Sonoma

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.